XML 24 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Jan. 02, 2016
Cash flows from operating activities:      
Net income $ 133,354 $ 107,224 $ 85,279
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 302,100 289,908 269,904
Deferred income taxes (98,805) (11,532) 7,807
Loss/(gain) on sale of assets (237) 1,744 1,311
Gain on insurance proceeds from insurance settlement (1,427) (356) (561)
Increase/(decrease) in long-term pension liability 2,383 (430) (4,811)
Stock-based compensation expense 17,598 10,330 8,995
Write-off deferred loan costs 766 528 10,633
Deferred loan cost amortization 8,736 11,171 10,155
Equity in net income of unconsolidated subsidiaries (28,504) (70,379) (73,416)
Distributions of earnings from unconsolidated subsidiaries 26,761 26,317 26,589
Changes in operating assets and liabilities, net of effects from acquisitions:      
Accounts receivable 3,482 (22,796) 8,214
Income taxes refundable/payable 9,360 2,839 12,377
Inventories and prepaid expenses (15,022) 15,343 34,536
Accounts payable and accrued expenses 73,386 39,286 (11,449)
Other (23,344) (8,161) 35,396
Net cash provided by operating activities 410,587 391,036 420,959
Cash flows from investing activities:      
Capital expenditures [1] (274,168) (243,523) (229,848)
Acquisitions, net of cash acquired (12,144) (8,511) (377)
Investment in unconsolidated subsidiary (4,750) 0 0
Gross proceeds from sale of property, plant and equipment and other assets 8,090 7,329 3,840
Proceeds from insurance settlement 6,054 1,537 561
Payments related to routes and other intangibles (7,135) (23) (3,845)
Net cash used in investing activities (284,053) (243,191) (229,669)
Cash flows from financing activities:      
Proceeds from long-term debt 33,401 36,327 590,745
Payments on long-term debt (149,623) (204,428) (609,255)
Borrowings from revolving credit facility 199,495 99,276 78,244
Payments on revolving credit facility (204,935) (104,028) (166,755)
Net cash overdraft financing (714) 1,071 (1,261)
Deferred loan costs (6,717) (3,879) (17,310)
Issuance of common stock 22 188 171
Repurchase of common stock 0 (5,000) (5,912)
Minimum withholding taxes paid on stock awards (3,049) (1,843) (4,874)
Deductions of noncontrolling interest (17,451) 0 (87)
Distributions to noncontrolling interests (5,281) (1,552) (3,295)
Net cash used in financing activities (154,852) (183,868) (139,589)
Effect of exchange rate changes on cash flows 20,528 (6,297) (3,601)
Net increase/(decrease) in cash and cash equivalents (7,790) (42,320) 48,100
Cash and cash equivalents at beginning of year 114,564 156,884 108,784
Cash and cash equivalents at end of year 106,774 114,564 156,884
Supplemental disclosure of cash flow information:      
Accrued Capital Expenditures 1,521 (937) 5,325
Cash paid during the year for:      
Interest, net of capitalized interest 78,233 82,094 78,979
Income taxes, net of refunds 26,304 23,220 (3,035)
Non-cash financing activities      
Debt issued for service contract assets 9,459 10 2,591
Contribution of Property $ 0 $ 2,674 $ 0
[1] Excludes immaterial capital assets acquired by acquisition in fiscal 2017, fiscal 2016 and fiscal 2015.